Jazz Pharmaceuticals (JAZZ) insider RSU tax withholding detailed

Rhea-AI Filing Summary

Jazz Pharmaceuticals EVP & Chief Legal Officer Neena M. Patil had 2,678 Ordinary Shares withheld on June 30, 2026 to cover taxes from vesting restricted stock units. The shares were not sold on the open market but used to satisfy tax obligations.

After this tax-withholding disposition, Patil directly holds 48,871 Ordinary Shares. This type of transaction is routine for equity-based compensation and does not represent a discretionary purchase or sale decision.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Patil Neena M

Role EVP & Chief Legal Officer

Type	Security	Shares	Price	Value
Tax Withholding	Ordinary Shares	2,678	$237.72	$637K

Holdings After Transaction: Ordinary Shares — 48,871 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares withheld for taxes: 2,678 shares Reference price per share: $237.72/share Shares held after transaction: 48,871 shares

3 metrics

Shares withheld for taxes 2,678 shares Tax-withholding disposition on June 30, 2026

Reference price per share $237.72/share Value used for tax-withholding shares

Shares held after transaction 48,871 shares Direct Ordinary Shares held by Neena M. Patil after withholding

Key Terms

restricted stock units, tax-withholding disposition, Ordinary Shares

3 terms

restricted stock units financial

"vesting of a portion of previously granted restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax-withholding disposition financial

"transaction_action": "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Ordinary Shares financial

"security_title": "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 06:10 PM Accepted by SEC EDGAR 07/02/2026 - 06:09 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Patil Neena M

(Last) (First) (Middle)

5TH FL, WATERLOO EXCHANGE

WATERLOO RD

(Street)

DUBLIN 4

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Jazz Pharmaceuticals plc [ JAZZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/30/2026		F(1)		2,678	D	$237.72	48,871	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

	By: /s/Paz Dizon, as attorney in fact For: Neena M. Patil	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Jazz Pharmaceuticals (JAZZ) report for Neena M. Patil?

Jazz Pharmaceuticals reported that EVP & Chief Legal Officer Neena M. Patil had 2,678 Ordinary Shares withheld to cover taxes from vesting restricted stock units. This was a tax-withholding disposition, not an open-market trade, and reflects routine handling of equity compensation.

Was the Jazz Pharmaceuticals (JAZZ) Form 4 a stock sale by the insider?

No, the Form 4 shows a tax-withholding disposition, not an open-market stock sale. Shares were withheld by the company to satisfy tax obligations triggered by the vesting of restricted stock units, a common administrative step in equity compensation programs.

How many Jazz Pharmaceuticals (JAZZ) shares were involved in the tax withholding?

The filing states that 2,678 Ordinary Shares were withheld at a reference price of $237.72 per share. These shares were used to satisfy tax obligations arising from the vesting of previously granted restricted stock units, rather than being voluntarily sold in the market.

How many Jazz Pharmaceuticals (JAZZ) shares does Neena M. Patil hold after this transaction?

After the tax-withholding transaction, Neena M. Patil directly holds 48,871 Ordinary Shares of Jazz Pharmaceuticals. This remaining position provides context that the withheld shares represent a relatively small portion of her overall direct holdings at the company.

What does a tax-withholding disposition mean for Jazz Pharmaceuticals (JAZZ) investors?

A tax-withholding disposition means the company retains some shares from vesting awards to pay the insider’s tax obligations. It is a mechanical, compensation-related event and generally does not signal any change in the insider’s outlook on Jazz Pharmaceuticals stock.